End-tidal carbon dioxide concentration in the expired air (ETCO2) is m
easured with different technologies. ETCO2 allows the global evaluatio
n of three main body functions: metabolism, circulation and ventilatio
n. If two of these parameters are held constant, changes in ETCO2 refl
ect a variation of the third. Thus, ETCO2 is now widely used as a reli
able monitoring device in various clinical settings. In the past years
several studies proposed ETCO2 as a non-invasive monitor for the eval
uation of therapeutic efforts during low-flow states, and especially d
uring cardiopulmonary resuscitation. However, recent laboratory and cl
inical investigations demonstrated that various pharmacological and ph
ysical interventions may influence ETCO2. Especially, the use of the C
O2 generating buffer NaHCO3 increase and alpha-adrenergic agents const
antly decrease ETCO2. Thus, although ETCO2 remains a necessary tool du
ring anaesthesia, it may loose the potential for prediction of surviva
l when monitoring the resuscitative efforts during cardiopulmonary res
uscitation.